Antoon H van Lierop

Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover

Antoon H van Lierop, Neveen A. T. Hamdy, Herman A. Hamersma et al. · Journal of Bone and Mineral Research · 2011 · 133 citations · Full text

Sclerostin, Disease Carriers, Immunology +18

Van Buchem disease: Clinical, biochemical, and densitometric features of patients and disease carriers

Antoon H van Lierop, Neveen A. T. Hamdy, Martje E. van Egmond et al. · Journal of Bone and Mineral Research · 2012 · 121 citations · Full text

Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls

Antoon H van Lierop, Janneke Witteveen, Neveen A. T. Hamdy et al. · European Journal of Endocrinology · 2010 · 101 citations

Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus

Antoon H van Lierop, Neveen A. T. Hamdy, R.W. van der Meer et al. · European Journal of Endocrinology · 2012 · 75 citations

Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnover

Maria P. Yavropoulou, Antoon H van Lierop, Neveen A. T. Hamdy et al. · Bone · 2012 · 60 citations · Full text

Serum Sclerostin Levels, Urology, Sclerostin +7